Ashland Inc. appoints William G. Dempsey to board of directors
July 20 2016 - 4:23PM
July 20, 2016
COVINGTON, Ky. - Ashland Inc. (NYSE: ASH) today
announced it has appointed William G. Dempsey, a long-time
pharmaceutical industry executive, to its board of directors.
Dempsey previously served in various executive
positions with Abbott Laboratories from 1982-2007, including
executive vice president of global pharmaceuticals from 2006,
senior vice president of pharmaceutical operations from 2003 and
senior vice president of international operations from 1999. He
currently serves as a director of Landauer Inc. (NYSE: LDR) and
Hill-Rom Holdings (NYSE: HRC). He also served on the board of
Hospira, Inc. through September 2015 and Nordion, Inc. through
2014. Dempsey has previously served as chairman of the
International Section of the Pharmaceutical Research and
Manufacturers of America (PhRMA) and as chairman of the
Accelerating Access Initiative, a cooperative public-private
partnership of UNAIDS, the World Bank and six research-based
pharmaceutical companies. He also previously served as member of
the Salvation Army Advisory Board in Chicago. Dempsey continues to
serve on the board of trustees for the Guadalupe Center in
Immokalee, Florida.
"Bill's significant experience within the
pharmaceutical industry - a core growth market for Ashland - as
well as within international operations makes him an ideal addition
to the Ashland board," said William A. Wulfsohn, Ashland chairman
and chief executive officer. "We believe his strategic insights and
industry perspective will prove valuable as we position Ashland to
be the world's premier specialty chemicals company."
About Ashland
Ashland Inc. (NYSE: ASH) is a global leader in providing specialty
chemical solutions to customers in a wide range of consumer and
industrial markets, including adhesives, architectural coatings,
automotive, construction, energy, food and beverage, personal care
and pharmaceutical. Through our three business units - Ashland
Specialty Ingredients, Ashland Performance Materials and Valvoline
- we use good chemistry to make great things happen for customers
in more than 100 countries. Visit ashland.com to learn more.
- 0 -
C-ASH
Non-solicitation
A registration statement relating to the securities of Ashland
Global Holdings Inc. has been filed with the SEC but has not yet
become effective. These securities may not be sold nor may offers
to buy these securities be accepted before the time the
registration statement becomes effective. This news release shall
not constitute an offer to sell or a solicitation of an offer to
buy securities, and shall not constitute an offer, solicitation or
sale in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of that jurisdiction.
Additional
Information and Where to Find It
In connection with its plan to reorganize under a new public
holding company, Ashland filed with the SEC the Ashland Global
Holdings Inc. registration statement (the "Ashland Global
Registration Statement") that includes a proxy statement of Ashland
Inc. that also constitutes a prospectus of Ashland Global Holdings
Inc. (which Ashland Global Registration Statement has not yet been
declared effective). INVESTORS AND SECURITY HOLDERS ARE URGED TO
READ THE PROXY STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT
DOCUMENTS WHEN THEY BECOME AVAILABLE, BECAUSE THEY CONTAIN, OR WILL
CONTAIN, IMPORTANT INFORMATION ABOUT ASHLAND INC., ASHLAND GLOBAL
HOLDINGS INC. AND THE REORGANIZATION. A definitive proxy statement
will be sent to shareholders of Ashland Inc. seeking approval of
the reorganization after the Ashland Global Registration Statement
is declared effective. The proxy statement/prospectus and other
documents relating to the reorganization can be obtained free of
charge from the SEC website at www.sec.gov.
Participants in
Solicitation
This communication is not a solicitation of a proxy from any
investor or shareholder. However, Ashland Inc., Ashland Global
Holdings Inc. and certain of their directors and executive officers
may be deemed to be participants in the solicitation of proxies in
connection with the reorganization under the rules of the SEC.
Information regarding Ashland Inc.'s directors and executive
officers may be found in its definitive proxy statement relating to
its 2016 Annual Meeting of Shareholders filed with the SEC on
December 4, 2015 and in the proxy statement/prospectus included in
the Ashland Global Registration Statement. Information regarding
Ashland Global Holdings Inc.'s directors and executive officers may
be found in the proxy statement/prospectus included in the Ashland
Global Registration Statement. These documents can be obtained free
of charge from the SEC.
FOR FURTHER
INFORMATION:
Investor Relations:
Seth A.
Mrozek
+1 (859) 815-3527
samrozek@ashland.com
Media Relations:
Gary
Rhodes
+1 (859) 815-3047
glrhodes@ashland.com
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Ashland Inc. via Globenewswire
HUG#2029808
Ashland (NYSE:ASH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ashland (NYSE:ASH)
Historical Stock Chart
From Sep 2023 to Sep 2024